Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Sucampo Pharmaceuticals, Inc.    SCMP

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Manufactures pharmaceuticals and health care products

Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company, which is engaged in developing, identifying, acquiring and bringing medicines that meet unmet medical needs.

It focuses on gastroenterology, ophthalmology, and oncology-related disorders.

The company's product pipeline includes AMITIZA for the treatment of chronic idiopathic constipation in adults; irritable bowel syndrome with constipation in adult women; opioid-induced constipation in patients with chronic non-cancer pain; chronic constipation; and pediatric functional constipation.

Its product pipeline also consists of Unoprostone Isopropyl, which is in Phase III trial for the treatment of retinitis pigmentosa and in pre-clinical stage for the treatment of geographic atrophy; and Cobiprostone that has completed Phase Ib trial for the treatment of oral mucositis, as well as in Phase II trial for the treatment of non-erosive reflux diseases.

Sucampo Pharmaceuticals was founded by Dr. Ryuji Ueno and Dr. Sachiko Kuno on December 5, 1996 and is headquartered in Bethesda, MD.

Number of employees : 139 persons.
Sales per Businesses
20152016Delta
USD (in Million)%USD (in Million)%
Pharmaceutical Products153.18100%230.06100% +50.19%
Sales per Regions
20152016Delta
USD (in Million)%USD (in Million)%
United States95.7762.5%140.2461% +46.44%
Japan55.3736.1%83.1336.1% +50.13%
Rest of the World2.041.3%6.692.9% +227.75%
Managers
NameAgeSinceTitle
Peter S. Greenleaf, MBA472014Chairman & Chief Executive Officer
Peter P. Pfreundschuh MBA, CPA472017Chief Financial Officer
Peter Lichtlen MD, PhD492011Chief Medical Officer
Peter Alec Kiener, PhD642014Chief Scientific Officer
Matthew Maxwell Donley, MBA482014EVP-Human Resources & Information Technology
Maureen E. O'Connell, CPA552013Independent Director
John H. Johnson592014Lead Independent Director
Robert Jay Spiegel, MD662015Director
Timothy P. Walbert492015Director
Paul R. Edick622016Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 46,779,728 25,456,324 54.4% 227,266 0.5% 54.4%
Shareholders
NameEquities%
Ryuji Ueno, MD, PhD 10,537,628 22.7%
Sachiko Kuno, PhD 10,537,627 22.7%
BlackRock Fund Advisors 3,612,634 7.78%
Krensavage Asset Management LLC 2,819,708 6.07%
LSV Asset Management 2,390,418 5.14%
The Vanguard Group, Inc. 1,646,348 3.54%
Dimensional Fund Advisors LP 1,570,172 3.38%
New Enterprise Associates LLC 1,258,507 2.71%
Royce & Associates LP 1,067,923 2.30%
Millennium Management LLC 1,011,477 2.18%
Sector Bio Therapeutic Drugs
1st jan.Capitalization (M$)
SUCAMPO PHARMACEUTICALS, INC.-25.83%477
AMGEN14.42%122 067
CELGENE CORPORATION10.28%99 867
GILEAD SCIENCES0.70%94 170
REGENERON PHARMACEUTICALS26.41%50 145
VERTEX PHARMACEUTICALS101.07%37 346
ACTELION22.00%30 302
GENMAB12.87%12 817
EXELIXIS, INC.76.59%7 739
KITE PHARMA INC181.07%7 444
TESARO INC-18.91%6 169
BIOVERATIV INC0.00%5 955
TONGHUA DONGBAO PHARMACEUTICAL CO., LTD.-17.33%4 638
NEUROCRINE BIOSCIENCES, INC.34.75%4 601
BLUEBIRD BIO INC51.13%4 215
HUALAN BIOLOGICAL ENGINEERING INC--.--%4 034
PEPTIDREAM INC-42.43%3 673
CLOVIS ONCOLOGY INC62.00%3 517
BIOCON LTD3.80%3 077
AVEXIS INC93.97%2 956
JUNO THERAPEUTICS INC43.55%2 870
Connections : Sucampo Pharmaceuticals, I
The Arthritis Foundation
VirMedica, Inc.
Resolve Therapeutics LLC
Cempra Pharmaceuticals, Inc.
Biotechnology Innovation Organization
Illinois Innovation Council
Swiss Association of Pharmaceutical Professionals, Inc.
Cortendo AB (publ)
Chicagonext
Pharmaceutical Research & Manufacturers of America
Vicuron Pharmaceuticals, Inc.
The W2O Group
Scholastic, Inc.
Horizon Pharma USA, Inc.
Maryland Venture Fund
FMH Swiss Medical Association
Vidac Pharma Ltd.
Illinois Biotechnology Industry Organization
Sucampo AG
World Business Chicago
Numab AG
MATTER Chicago
Avior Computing Corp.
Xeris Pharmaceuticals, Inc.
Weill Cornell Medical College
Iterum Therapeutics Ltd.
TetraGenetics, Inc.
Spiegel Consultants, LLC
NexImmune, Inc.
3G Advisors LLC
Company contact information
Sucampo Pharmaceuticals, Inc.
805 King Farm Boulevard
Suite 550
Rockville, MD 20850

Phone : +1.301.961.3400
Fax : +1.301.961.3440
Web : www.sucampo.com
© 2017 People , Fundamentals and Ownership